Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01457768 · ClinicalTrials.gov registry record
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
A clinical trial of Hepatitis C, Chronic, sponsored by Gilead Sciences.
- Completed
- Registry status
- 570
- Enrollment target
- 20
- Study locations
NCT01457768 is a study of Hepatitis C, Chronic that has completed, run by Gilead Sciences. The registered enrollment target is 570 participants, above the 354-participant average among 26 other Hepatitis C, Chronic trials with a reported enrollment target (61% higher). The trial reports 20 study locations across 3 states.
The verdict
NCT01457768, a study of Hepatitis C, Chronic, has completed, sponsored by Gilead Sciences.
- COMPLETED
- Registry status
- 570 participants
- Enrollment target
- 20
- Study locations
Study Summary
This Registry is designed to obtain long term data on participants who have failed to achieve sustained virologic response (SVR) while receiving at least one Gilead oral antiviral agent (OAV) in a previous Gilead-sponsored hepatitis C virus (HCV) study.
Conditions Studied
Study Locations (20)
California
- Advanced Clinical Research Institute, LLC - Anaheim
- Franco Felizarta, MD - Bakersfield
- Southern California Medical Group - Coronado
- West Coast Clinical Trials, LLC - Costa Mesa
- UC Davis Medical Center - Davis
- Kaiser Permanente Institute for Health Research - La Jolla
- Scripps Clinic - La Jolla
- University of California San Diego - La Jolla
- eStudySite - La Mesa
- VA Long Beach Healthcare System - Long Beach
- Kaiser Permanente of Colorado - Los Angeles
- Peter J. Ruane, MD, Inc. - Los Angeles
- 8631 West 3rd Street - Los Angeles
- California Liver Institute - Los Angeles
- Anthony Mills MD, Inc - Los Angeles
Alabama
- Birmingham Gastroenterology Associates - Birmingham
- University of Alabama at Birmingham - Birmingham
- Digestive Health Specialists - Dothan
Arizona
- Mayo Clinic - Phoenix
- University of Arizona - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 570 participants |
| Start Date | 2011-12-19 |
| Est. Completion | 2018-04-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01457768
The ClinicalTrials.gov registry entry for NCT01457768 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 570 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 354-participant average among 26 other Hepatitis C, Chronic trials with a reported enrollment target (61% higher). The listed sponsor is Gilead Sciences, which has 504 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hepatitis C, Chronic appearing as the primary indexed condition, and to 0 interventions.
NCT01457768 reports 20 study locations spanning 3 distinct geographic areas - top geographies include California, Alabama, Arizona.
Frequently Asked Questions
What is clinical trial NCT01457768 about?
NCT01457768 is a clinical study titled "A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response". This Registry is designed to obtain long term data on participants who have failed to achieve sustained virologic response (SVR) while receiving at least one Gilead oral antiviral agent (OAV) in a previous Gilead-sponsored hepatitis C virus (HCV) study.
What is the current status of trial NCT01457768?
This trial is currently completed. The enrollment target is 570 participants. The study started on 2011-12-19. Estimated completion is 2018-04-09.
What conditions does trial NCT01457768 study?
This clinical trial studies the following conditions: Hepatitis C, Chronic.
Who is sponsoring clinical trial NCT01457768?
This trial is sponsored by Gilead Sciences, which has 504 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01457768 being conducted?
This trial has 20 study locations across Alabama, Arizona, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis C, Chronic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy
RECRUITING · Phase 4
-
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
ACTIVE NOT RECRUITING · Phase 4
-
IdB 1016 Treatment for Hepatitis C Disease
COMPLETED · Phase 1
-
A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV
COMPLETED · Phase 2
-
A Safety and Effectiveness Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment
COMPLETED · Phase 3
-
Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.